61 related articles for article (PubMed ID: 8840966)
1. A p18 mutant defective in CDK6 binding in human breast cancer cells.
Lapointe J; Lachance Y; Labrie Y; Labrie C
Cancer Res; 1996 Oct; 56(20):4586-9. PubMed ID: 8840966
[TBL] [Abstract][Full Text] [Related]
2. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.
Blais A; Labrie Y; Pouliot F; Lachance Y; Labrie C
Biochem Biophys Res Commun; 1998 Jun; 247(1):146-53. PubMed ID: 9636670
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
Zariwala M; Liu E; Xiong Y
Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
[TBL] [Abstract][Full Text] [Related]
4. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
5. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
Noh SJ; Li Y; Xiong Y; Guan KL
Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
7. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
8. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
[TBL] [Abstract][Full Text] [Related]
11. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
12. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump J; Turner S; Koh J
Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
[TBL] [Abstract][Full Text] [Related]
13. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
14. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of extremely low frequency electromagnetic fields on cyclin-dependent kinase 4 inhibitor gene p18(INK4C) in electric energy workers.
Erdal N; Erdal ME; Gürgül S
Arch Med Res; 2005; 36(2):120-3. PubMed ID: 15847943
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c.
Nishimura N; Furukawa Y; Sutheesophon K; Nakamura M; Kishi K; Okuda K; Sato Y; Kano Y
Oncogene; 2003 Jun; 22(26):4074-82. PubMed ID: 12821941
[TBL] [Abstract][Full Text] [Related]
18. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
